A small study finds no cancer recurrences after two years in patients who skipped breast surgery following a complete response to chemotherapy—but experts say the research is in its very early stages.
When teacher Ellen Reich began treatment for multiple myeloma in 2014, a sequence of therapies approved by the U.S. Food and Drug Administration (FDA) kept her cancer in check for over five years. Eventually,...
A study found women in California were more likely to have cervical cancer diagnoses at a later stage after age 65.
Immunotherapy before surgery is proving to be an effective treatment against melanoma.
Therapeutic antibodies carry ‘payloads’ to destroy cancer cells.
Neurologist David Schiff discusses the significance of new evidence-based guidance on how to treat brain metastases from solid tumors.
Cardiovascular mortality rates for survivors of early-stage Hodgkin lymphoma outpace cancer-related mortality.
Technology could help detect lymphedema earlier.
Scientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
Cancer treatment is a double-edged sword. Intense or multi-pronged treatment may lead to better killing of tumor cells, but it can often cause debilitating side effects. Is it possible to reduce the intensity of...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 54,000 members worldwide drive progress against cancer.
Donate Now